Celldex Therapeutics, Inc. (CLDX)
Nasdaq: CLDX · CIK 0000744218 · United States
Every official Celldex Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CLDX filings
Celldex Therapeutics, Inc. documents
- Celldex Therapeutics, Inc. 10-K 2026CLDX 10-K 2026: annual report for fiscal 2026
- Celldex Therapeutics, Inc. 10-K 2025CLDX 10-K 2025: annual report for fiscal 2025
- Celldex Therapeutics, Inc. 10-K 2024CLDX 10-K 2024: annual report for fiscal 2024
- Celldex Therapeutics, Inc. 10-K 2023CLDX 10-K 2023: annual report for fiscal 2023
- Celldex Therapeutics, Inc. 10-K 2022CLDX 10-K 2022: annual report for fiscal 2022
- Celldex Therapeutics, Inc. 10-Q 2026CLDX 10-Q 2026: quarterly report for fiscal 2026
- Celldex Therapeutics, Inc. 10-Q 2025CLDX 10-Q 2025: quarterly report for fiscal 2025
- Celldex Therapeutics, Inc. 10-Q 2024CLDX 10-Q 2024: quarterly report for fiscal 2024
- Celldex Therapeutics, Inc. 10-Q 2023CLDX 10-Q 2023: quarterly report for fiscal 2023
- Celldex Therapeutics, Inc. 10-Q 2022CLDX 10-Q 2022: quarterly report for fiscal 2022
- Celldex Therapeutics, Inc. 8-K 2026CLDX 8-K 2026: current report for fiscal 2026
- Celldex Therapeutics, Inc. 8-K 2025CLDX 8-K 2025: current report for fiscal 2025
- Celldex Therapeutics, Inc. 8-K 2024CLDX 8-K 2024: current report for fiscal 2024
- Celldex Therapeutics, Inc. 8-K 2023CLDX 8-K 2023: current report for fiscal 2023
- Celldex Therapeutics, Inc. 8-K 2022CLDX 8-K 2022: current report for fiscal 2022
- Celldex Therapeutics, Inc. DEF 14A 2026CLDX DEF 14A 2026: proxy statement for fiscal 2026
- Celldex Therapeutics, Inc. DEF 14A 2025CLDX DEF 14A 2025: proxy statement for fiscal 2025
- Celldex Therapeutics, Inc. DEF 14A 2024CLDX DEF 14A 2024: proxy statement for fiscal 2024
- Celldex Therapeutics, Inc. DEF 14A 2023CLDX DEF 14A 2023: proxy statement for fiscal 2023
- Celldex Therapeutics, Inc. DEF 14A 2022CLDX DEF 14A 2022: proxy statement for fiscal 2022
- Celldex Therapeutics, Inc. Form 4 2026CLDX Form 4 2026: insider trading filing for fiscal 2026
- Celldex Therapeutics, Inc. Form 4 2025CLDX Form 4 2025: insider trading filing for fiscal 2025
- Celldex Therapeutics, Inc. Form 4 2024CLDX Form 4 2024: insider trading filing for fiscal 2024
- Celldex Therapeutics, Inc. Form 4 2023CLDX Form 4 2023: insider trading filing for fiscal 2023
- Celldex Therapeutics, Inc. Form 4 2022CLDX Form 4 2022: insider trading filing for fiscal 2022
- Celldex Therapeutics, Inc. S-1 2026CLDX S-1 2026: registration statement for fiscal 2026
- Celldex Therapeutics, Inc. S-1 2025CLDX S-1 2025: registration statement for fiscal 2025
- Celldex Therapeutics, Inc. S-1 2024CLDX S-1 2024: registration statement for fiscal 2024
- Celldex Therapeutics, Inc. S-1 2023CLDX S-1 2023: registration statement for fiscal 2023
- Celldex Therapeutics, Inc. S-1 2022CLDX S-1 2022: registration statement for fiscal 2022
- Celldex Therapeutics, Inc. 13F 2026CLDX 13F 2026: institutional holdings for fiscal 2026
- Celldex Therapeutics, Inc. 13F 2025CLDX 13F 2025: institutional holdings for fiscal 2025
- Celldex Therapeutics, Inc. 13F 2024CLDX 13F 2024: institutional holdings for fiscal 2024
- Celldex Therapeutics, Inc. 13F 2023CLDX 13F 2023: institutional holdings for fiscal 2023
- Celldex Therapeutics, Inc. 13F 2022CLDX 13F 2022: institutional holdings for fiscal 2022
More companies